Sheldon Jerome Davidson MD FACP

Oncology•Los Angeles, CA

partner,West Valley Hem/Onc Med Group Clinical Prof Of Med,UCLA

Join to View Full Profile

10833 Le Conte Ave., 60-054 CHSLos Angeles, CA 90095
Phone+1 310-825-5756
Fax+1 310-825-5756

Education & Training

University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1971 - 1973
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1967 - 1968
Maimonides Medical CenterResidency, Internal Medicine, 1964 - 1967
Albert Einstein College of MedicineClass of 1964

Certifications & Licensure

CA State Medical License 1968 - 2027
AZ State Medical License 1964 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

Top Doctors:LA Area Castle Connolly, 2013
Top Doctors:Southern California Castle Connolly, 2012
Fellow (FACP) American College of Physicians, 1996
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2009 Apr 01
Completed
Phase 2
Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer Start of enrollment: 2009 Sep 10
Completed
Phase 3
Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer Start of enrollment: 2009 Sep 01
Completed
Phase 2
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery Start of enrollment: 2011 Jan 13
Completed
Phase 2
Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2014 Feb 05
Terminated
Phase 3
A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study) Start of enrollment: 2013 Dec 13
Terminated
Phase 2
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer Start of enrollment: 2014 May 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

12 citations
Phase I study of everolimus, cetuximab and irinotecan as second-line therapy in metastatic colorectal cancer.
J. Randolph Hecht, Tony R. Reid, Christopher R. Garrett, J. Thaddeus Beck, Sheldon J. Davidson
Anticancer Research. 2015-03-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American College of Physicians - ACP
Fellow

Other Languages

Spanish, Tagalog, Korean, Farsi